In vitro variability in fentanyl absorption by different membrane oxygenators

Lunn, 1979, High-dose fentanyl anesthesia for coronary artery surgery: Plasma fentanyl concentrations and influence of nitrous oxide on cardiovascular responses, Anesth Analg, 58, 390 Bentley, 1983, Fentanyl sequestration in lungs during cardiopulmonary bypass, Clin Pharmacol Ther, 34, 703, 10.1038/clpt.1983.235 Wynands, 1983, Blood pressure response and plasma fentanyl concentrations during high- and very high-dose fentanyl anesthesia for coronary artery surgery, Anesth Analg, 62, 661, 10.1213/00000539-198307000-00007 Bovill, 1980, Pharmacokinetics of highdose fentanyl, Br J Anaesth, 52, 795, 10.1093/bja/52.8.795 Koren, 1984, Sequestration of fentanyl by the cardiopulmonary bypass, Eur J Clin Pharmacol, 27, 51, 10.1007/BF02395206 Koren, 1984, Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery, Anesth Analg, 63, 577, 10.1213/00000539-198406000-00005 Skacel, 1986, Extracorporeal circuit sequestration of fentanyl and alfentanil, Br J Anaesth, 58, 947, 10.1093/bja/58.9.947 Rosen, 1988, Fentanyl Uptake by the SciMed membrane oxygenator, J Cardiothorac Anesth, 2, 619, 10.1016/0888-6296(88)90054-3 Koska, 1981, Effect of cardiopulmonary bypass on fentanyl distribution and elimination, Clin Pharmacol Ther, 29, 100, 10.1038/clpt.1981.16 Hynynen, 1986, Continuous infusion of fentanyl or alfentanil for coronary artery surgery. Plasma opiate concentrations, haemodynam ics, and postoperative course, Br J Anaesth, 58, 1252, 10.1093/bja/58.11.1252 Koren, 1984, Irreversible binding of fentanyl to the cardiopulmonary bypass, Anesth Analg, 63, 236